B

BioVersys
BIOV

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CHF140.30M
EV
CHF66.48M
Shares Outstanding
5.96M
Beta
-
Industry
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
3
P/E 2025E
-
P/Revenue 2025E
43.17x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioVersys AG

gainify

B

BioVersys AG

BIOV

BioVersys AG, a clinical stage biopharmaceutical company, focuses on identification, development, and commercialization of novel antibacterial products for serious life-threatening infections caused by multi-drug-resistant bacteria. It develops BV100 that is in Phase ...

Sector

Industry

CEO

Gitzinger, Marc

Employees

29

IPO Date

Headquarters

Hochbergerstrasse 60c, Basel, Basel-Stadt, 4057, Switzerland

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.